Amicogen, Inc.
KOSDAQ-listed industrial biotech producing cephalosporin precursor enzyme CX and antibody-purification Protein A resin.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2000 and listed on KOSDAQ in 2013, Amicogen is an industrial biotech company specializing in specialty pharmaceutical enzymes and enzyme-based bio-materials. It develops and commercializes CX enzyme for manufacturing the cephalosporin precursor 7-ACA, SP enzymes for penicillin-class antibiotics, SC enzymes for cephalosporin-class antibiotics, Protein A resin for antibody purification, and culture media products, alongside healthcare materials (N-acetylglucosamine, D-chiro-inositol, pinitol, collagen peptide/tripeptide) and its K-NUTRA brand business. Since 2020, it has partnered with Lysando of Liechtenstein to commercialize an endolysin enzyme.
Products & technology
- CX enzymeEnzyme for manufacturing 7-ACA, a cephalosporin antibiotic precursor
- SP enzymesSynthetic enzymes for penicillin-class antibiotics including amoxicillin
- SC enzymesSynthetic enzymes for cephalosporin-class antibiotics including cefotaxime
- Protein A resinAffinity chromatography resin for antibody biopharmaceutical purification
- Cell culture mediaCulture media for biopharmaceutical production
- Healthcare materials (N-acetylglucosamine, D-chiro-inositol, pinitol, collagen peptide/tripeptide)Health functional ingredient materials
- K-NUTRAConsumer brand business
- Endolysin enzymeNext-generation antibiotic for treating superbugs
Regulatory approvals
data.go.kr1 Korean MFDS device approvals · 2022
- MFDSChemiluminescence assay(CLIA) analyzer2022-05-31Product approval · Class 1체외 수신 22-963 호
R&D and key agreements
Source: DART corporate disclosure엔돌라이신 효소 · 슈퍼박테리아 감염 · 사업화 추진중 · Collaboration with Lysando (Liechtenstein) since 2020
Companies approved for the same productsBiotech & Drug Discovery
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSDAQ-listed bioprocess and biomedical company supplying the CELBIC single-use cell culture system and the DxBIC automated analysis system.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
KOSDAQ-listed IVD company selling AlzOn and AlzOn+ blood-based oligomeric beta-amyloid tests for Alzheimer's risk assessment.
KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.
KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.
Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.
Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition